Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease. - Wikidata - awgldk - TriplyDB

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

http://www.wikidata.org/entity/Q46165385

about

Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications: A UK Cost-Effectiveness Analysis Technology for deep brain stimulation at a gallop Deep brain stimulation for movement disorders Twiddler (or Not) Syndrome: Questioning etiology for an uncommon form of hardware malfunction in deep brain stimulation Clinical Impact and Cost-Effectiveness of an Education Program for PD Patients: A Randomized Controlled Trial.The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease Subthalamic nucleus-deep brain stimulation for early motor complications in Parkinson's disease-the EARLYSTIM trial: early is not always better.Deep brain stimulation for Parkinson disease in Australia: current scientific and clinical status.Estimating the direct and indirect costs associated with Parkinson's disease.Advances in closed-loop deep brain stimulation devices.Economic Burden Analysis of Parkinson's Disease Patients in China Disease-specific longevity of impulse generators in deep brain stimulation and review of the literature.An economic evaluation of deep brain stimulation for patients with Parkinson's disease.Cost-utility analysis of deep brain stimulation surgery plus best medical therapy versus best medical therapy in patients with Parkinson's: Economic evaluation alongside the PD SURG trial.Shaking Up the Debate: Ensuring the Ethical Use of DBS Intervention Criteria for Mid-Stage Parkinson's Patients.Cost-Effectiveness of Deep Brain Stimulation for Advanced Parkinson's Disease in the United States.Deep Brain Stimulation Can Preserve Working Status in Parkinson's Disease.Neurotech report.Cost-effectiveness of neurostimulation in Parkinson's disease with early motor complications.Cost of deep brain stimulation for the treatment of Parkinson's disease by surgical stimulation sites.Deep brain stimulation of the subthalamic nucleus: All that glitters isn't gold?Cost-utility analysis alongside the PD SURG trial.The potential price and access implications of the cost-utility and budget impact methodologies applied by NICE in England and ICER in the US for a novel gene therapy in Parkinson's disease

P2860

Q26779605-F9CDA7AD-2194-4EA2-9396-CC7BDD349352 Q28081237-8BE0E199-4562-405E-BEE0-A694EF23EC5A Q30585845-B0F98FC5-F4E2-445A-88C5-825D52C56DAE Q34236291-87802094-10AE-4A68-AA49-1F06AC5A2A3D Q36148422-6FC4E59B-48CB-4911-89A7-55A8F7EB5C60 Q37491322-4A8F3EB0-9BB0-4590-A390-DF1F3C350757 Q38250175-7F61FEFD-CD52-4696-AA86-81788F7AC414 Q38343742-51A824A8-7E98-4D72-907B-8E893B155B23 Q38618871-914B972D-0698-43AC-AE4E-A32FD913D338 Q38643667-C68FBB43-1770-4F8A-A16C-835657701EF5 Q38659681-911B7D44-1FF5-4E14-9C57-9040213478FC Q38838977-43D40BA3-B620-4DD1-806A-C64DA9CA9F8A Q38871192-A0706226-5942-4337-9AEB-F2510AC7AF56 Q38912031-0CB98514-D252-4D6C-8F2E-D74A87BB1B4B Q39301896-E2CCF0DC-EC22-49A0-93A9-96EBA5FFB218 Q39524073-FFCF50B0-FC8A-49A8-BE39-C31C843AF46D Q40620719-BAF63F3D-2AE3-4175-BB9D-2946B088240D Q45716173-39F2ED3A-7092-4EDC-8460-4D438B31255A Q47679196-3F68207A-A5EB-4644-807E-77D32E621B12 Q48065494-46184557-C6B8-4794-B737-B7CC50E8E603 Q48345426-AEE440A1-D06B-4F27-A443-2D27C7D85503 Q50208748-85881EA2-8018-4EC5-B258-37C0C0FE2590 Q58566132-ED11A041-3EF0-4DB8-A5D7-79B3A510693C

P2860

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

http://www.wikidata.org/entity/Q46165385

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@en

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@nl

type

label

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@en

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@nl

prefLabel

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@en

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@nl

P1433

Q46165385-7BF103A1-F2A8-446D-B99F-6A48B3E69A82

P1476

Q46165385-6A3B05D5-C936-4BE7-9EE2-6C32B86E6AE4

P2093

Q46165385-59189013-30EA-4C1C-971B-0444174FB9EC

Q46165385-6E5C8EB3-B7A8-455B-A5D3-FEA2224FA032

Q46165385-7973A522-0946-4133-B3F5-C54424D9179D

Q46165385-803D6C70-CB15-47B4-96DA-DFA9DE7C471A

Q46165385-DFB591E0-D35F-47FB-8351-20DEFE24BF37

P2860

Q46165385-04398551-492B-4FA3-A433-C652786DD891

Q46165385-0C8B5E35-B1FC-4728-8443-15A68506542C

Q46165385-1031C106-FA8B-48F3-AD63-025C756182D1

Q46165385-1F2301FF-CFA9-43F2-ABC1-DBA9F0FBE39F

Q46165385-295D48F1-7161-49AC-8131-7D8131EE110F

Q46165385-4118BE38-8453-46A6-821F-1CB7B670E6C9

Q46165385-4AD6F032-F97B-4C74-B70E-E9F94F50BB85

Q46165385-55A94159-149D-4B10-9E56-85003246B8F0

Q46165385-6636145A-122E-4DC9-B1AA-91E7C68E9547

Q46165385-7043C397-5D04-4AB5-B24D-B51CE4D3CB7B

P304

Q46165385-32494391-EF00-485C-9D44-0224BA89521D

P31

Q46165385-E9CA77AE-46F2-4375-80D8-24BDFD23BFA7

P356

Q46165385-5B81C979-53A1-4043-BD32-26C0B8AEADA5

P407

Q46165385-278D8281-8385-4660-B162-669CD1D69283

P433

Q46165385-2583ADFE-DC88-4905-8D66-59BCF1CE9C96

P478

Q46165385-0607202A-214A-4778-A73F-517DBE586132

P50

Q46165385-481315F2-5C7A-4B75-BC4F-CF110942754D

Q46165385-48E7567C-132F-4072-AD20-6909A886A27B

Q46165385-4C4525EF-03D1-4C56-919A-CB39E19C89D0

P577

Q46165385-F3A6B745-B61A-4D30-A922-27C11BDD96F3

P5875

Q46165385-F4E8828A-78B2-458D-B685-81AAA62E4390

P698

Q46165385-51AA05B3-6B61-432A-A9C8-9022EC9B7D30

P921

Q46165385-766D2DC7-4D29-41B3-B64D-781C73D04F8C

Q46165385-9F10BE9E-73CF-439C-9356-4B5D3ADA0EB8

P356

P1433

Movement Disorders

P1476

Cost-effectiveness of deep brain stimulation in patients with Parkinson's disease.

@en

P2093

Bernhard Bornschein

http://www.w3.org/2001/XMLSchema#string

Jens-Peter Reese

http://www.w3.org/2001/XMLSchema#string

Judith Dams

http://www.w3.org/2001/XMLSchema#string

Richard Dodel

http://www.w3.org/2001/XMLSchema#string

Uwe Siebert

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinsonism: onset, progression and mortality

EuroQol--a new facility for the measurement of health-related quality of life

Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial.

Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes.

Systematic review of incidence studies of Parkinson's disease.

Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease.

Axial parkinsonian symptoms can be improved: the role of levodopa and bilateral subthalamic stimulation

The EQ-5D--a generic quality of life measure-is a useful instrument to measure quality of life in patients with Parkinson's disease.

Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow up

Systematic assessment of decision models in Parkinson's disease.

P304

763-771

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MDS.25407

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

28

http://www.w3.org/2001/XMLSchema#string

P50

Wolfgang H. Oertel

Günther Deuschl

P577

2013-04-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236192777

http://www.w3.org/2001/XMLSchema#string

P698

23576266

http://www.w3.org/2001/XMLSchema#string

P921

Parkinson's disease

deep brain stimulation